Title |
Sulforaphane inhibits growth of phenotypically different breast cancer cells
|
---|---|
Published in |
European Journal of Nutrition, February 2013
|
DOI | 10.1007/s00394-013-0499-5 |
Pubmed ID | |
Authors |
Anna Pawlik, Aleksandra Wiczk, Angelika Kaczyńska, Jędrzej Antosiewicz, Anna Herman-Antosiewicz |
Abstract |
Cancer development and resistance to chemotherapy correlates with aberrant activity of mitogenic pathways. In breast cancers, pro-survival PI3K-AktmTOR-S6K1 signaling pathway is often hyperactive due to overexpression of genes coding for growth factors or estrogen receptors, constitutive activation of PI3K or Akt and loss of PTEN, a negative regulator of the pathway. Since epidemiologic as well as rodent tumor studies indicate that sulforaphane (SFN), a constituent of many edible cruciferous vegetables, might be a potent inhibitor of mammary carcinogenesis, we analyzed the response of four breast cancer cell lines representing different abnormalities in ErbB2/ER-PI3K-AktmTOR-S6K1 signaling pathway to this compound. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 1% |
Unknown | 82 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 17% |
Student > Bachelor | 14 | 17% |
Student > Master | 12 | 14% |
Student > Ph. D. Student | 11 | 13% |
Other | 5 | 6% |
Other | 11 | 13% |
Unknown | 16 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 17 | 20% |
Agricultural and Biological Sciences | 16 | 19% |
Medicine and Dentistry | 11 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Nursing and Health Professions | 4 | 5% |
Other | 10 | 12% |
Unknown | 21 | 25% |